These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. Pollhammer M; Cursiefen C J Cataract Refract Surg; 2009 Mar; 35(3):588-9. PubMed ID: 19251154 [TBL] [Abstract][Full Text] [Related]
24. Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series. Sachdev R; Bansal S; Sinha R; Sharma N; Titiyal JS Ocul Immunol Inflamm; 2011 Oct; 19(5):343-5. PubMed ID: 21834698 [TBL] [Abstract][Full Text] [Related]
26. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Gangopadhyay N; Daniell M; Weih L; Taylor HR Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294 [TBL] [Abstract][Full Text] [Related]
27. Isolation of Kingella denitrificans from a corneal ulcer. Kim YH; Panday V; Reilly C Cornea; 2011 Apr; 30(4):472-3. PubMed ID: 21099406 [TBL] [Abstract][Full Text] [Related]
28. A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment. Miller WL; Giannoni AG; Perrigin J Cont Lens Anterior Eye; 2008 Aug; 31(4):201-6. PubMed ID: 18595770 [TBL] [Abstract][Full Text] [Related]
29. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. Gedik S; Akova YA; Gür S Cornea; 2006 Sep; 25(8):974-6. PubMed ID: 17102679 [TBL] [Abstract][Full Text] [Related]
30. Moxifloxacin resistance: intrinsic to antibiotic or related to mutation? Agarwal T; Jhanji V; Satpathy G; Nayak N; Chawla B; Tandon R; Titiyal JS Optom Vis Sci; 2012 Dec; 89(12):1721-4. PubMed ID: 23142880 [TBL] [Abstract][Full Text] [Related]
31. Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis. Liang SY; Lee GA J Cataract Refract Surg; 2011 May; 37(5):960-2. PubMed ID: 21511159 [TBL] [Abstract][Full Text] [Related]
32. Microbial keratitis secondary to infection with Citrobacter koseri. Goold LA; Warrier SK; Wittles NK; Nathan F Cornea; 2010 Apr; 29(4):479. PubMed ID: 20164753 [No Abstract] [Full Text] [Related]
33. Moxifloxacin for Buruli ulcer/HIV-coinfected patients: kill two birds with one stone? Author reply. O'Brien DP; Comte E; Ford N; Christinet V; Du Cros P AIDS; 2014 Jul; 28(12):1845-6. PubMed ID: 25006828 [No Abstract] [Full Text] [Related]
34. Semipermanent eyelash extensions causing bacterial keratitis: a case report. Ullrich K; Saha N Can J Ophthalmol; 2013 Jun; 48(3):e50-1. PubMed ID: 23769794 [No Abstract] [Full Text] [Related]
35. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Stroman DW; Dajcs JJ; Cupp GA; Schlech BA Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308 [TBL] [Abstract][Full Text] [Related]
36. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
37. Evidence-based review of moxifloxacin. O'Brien TP Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792 [No Abstract] [Full Text] [Related]